Chad J. Creighton, Ph.D.
Affiliations: | 2006 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Google:
"Chad Creighton"Parents
Sign in to add mentor| Kerby Shedden | grad student | 2006 | University of Michigan | |
| (Comparing gene expression profiles of cell culture models with profiles of tumor xenografts and patient tumors: Implications for lung and breast cancers.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Amara CS, Kami Reddy KR, Yuntao Y, et al. (2024) The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer. Nature Communications. 15: 1373 |
| Chen F, Zhang Y, Chandrashekar DS, et al. (2023) Global impact of somatic structural variation on the cancer proteome. Nature Communications. 14: 5637 |
| Monsivais D, Parks SE, Chandrashekar DS, et al. (2023) Using cancer proteomics data to identify gene candidates for therapeutic targeting. Oncotarget. 14: 399-412 |
| Zhang Y, Chen F, Creighton CJ. (2023) Pan-cancer molecular subtypes of metastasis reveal distinct and evolving transcriptional programs. Cell Reports. Medicine. 100932 |
| Creighton CJ. (2023) Gene Expression Profiles in Cancers and Their Therapeutic Implications. Cancer Journal (Sudbury, Mass.). 29: 9-14 |
| Garcia-Recio S, Hinoue T, Wheeler GL, et al. (2022) Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nature Cancer |
| Lin M, Ku AT, Dong J, et al. (2022) STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential. Oncogene |
| Si H, Zhao N, Pedroza A, et al. (2022) Noncanonical Wnt/Ror2 signaling regulates cell-matrix adhesion to prompt directional tumor cell invasion in breast cancer. Molecular Biology of the Cell. mbcE22020055 |
| Kundu ST, Rodriguez BL, Gibson LA, et al. (2022) The microRNA-183/96/182 cluster inhibits lung cancer progression and metastasis by inducing an interleukin-2-mediated antitumor CD8 cytotoxic T-cell response. Genes & Development |
| Zhang Y, Chen F, Chandrashekar DS, et al. (2022) Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways. Nature Communications. 13: 2669 |